Search

everythinglearnresearchcommunity

for

Search:↓

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

COVID-19 may worsen symptoms of benign prostatic hyperplasia (BPH).

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

Possible link between COVID-19 and hair loss; more research needed.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

COVID-19 affects many body systems, causing a wide range of symptoms and complications.

Covid-19 can cause skin and oral symptoms, like taste changes, which help in detection and management.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

COVID-19 affects multiple body systems, not just the lungs.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Sex hormones may affect COVID-19 severity and outcomes.

Testosterone's effects on COVID-19 are unclear and need more research.

Women with PCOS may be more susceptible to COVID-19 due to hormonal and psychological factors.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

Low testosterone may indicate severe COVID-19 in men.

Men may be more vulnerable to severe COVID-19 due to genetic and hormonal factors, but more research is needed.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

Low testosterone levels may lead to more severe COVID-19 outcomes.